Literature DB >> 7041814

Susceptibility testing of Campylobacter fetus subsp. jejuni, using broth microdilution panels.

G E Buck, M T Kelly.   

Abstract

Twenty-five isolates of Campylobacter fetus subsp. jejuni were tested by broth microdilution panels (Sensititre; GIBCO Diagnostics, Chagrin Falls, Ohio) and the minimal inhibitory concentrations (MICs) were compared with the corresponding MICs obtained by the standard agar dilution technique. Microdilution panels designed for testing gram-positive organisms were used so that erythromycin, the antibiotic of choice for this organism, could be included. The correlation with agar dilution was relatively poor when Mueller-Hinton broth was used; the MICs that were within one twofold dilution of the corresponding agar dilution MIC ranged from 15% with tetracycline to 75% with ampicillin. The overall agreement for all antibiotics tested was 48%. The correlation improved significantly, however, to an overall agreement of 87% when Wilkins-Chalgren broth was substituted in the broth microdilution procedure. Our results indicate that the broth microdilution test is an accurate method for testing this organism, provided than an appropriate medium is used.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7041814      PMCID: PMC181872          DOI: 10.1128/AAC.21.2.274

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

Review 1.  Campylobacter enteritis.

Authors:  J P Butzler; M B Skirrow
Journal:  Clin Gastroenterol       Date:  1979-09

Review 2.  The genus Campylobacter.

Authors:  R M Smibert
Journal:  Annu Rev Microbiol       Date:  1978       Impact factor: 15.500

3.  Susceptibility of related vibrios and Vibrio fetus to twelve antibiotics.

Authors:  J P Butzler; P Dekeyser; T Lafontaine
Journal:  Antimicrob Agents Chemother       Date:  1974-01       Impact factor: 5.191

4.  Transmissible tetracycline resistance in Campylobacter jejuni.

Authors:  D E Taylor; S A DeGrandis; M A Karmali; P C Fleming
Journal:  Lancet       Date:  1980-10-11       Impact factor: 79.321

5.  Erythromycin-resistant campylobacters.

Authors:  W A Brunton; A M Wilson; R M Macrae
Journal:  Lancet       Date:  1978 Dec 23-30       Impact factor: 79.321

6.  Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents.

Authors:  R Vanhoof; M P Vanderlinden; R Dierickx; S Lauwers; E Yourassowsky; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

7.  Susceptibility of Campylobacter fetus subsp. jejuni to twenty antimicrobiol agents.

Authors:  M Walder
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

8.  Campylobacter enteritis.

Authors:  M A Karmali; P C Fleming
Journal:  Can Med Assoc J       Date:  1979-06-23       Impact factor: 8.262

9.  Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni.

Authors:  R Vanhoof; B Gordts; R Dierickx; H Coignau; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

10.  Effect of several components of anaerobic incubation on antibiotic susceptibility test results.

Authors:  J E Rosenblatt; F Schoenknecht
Journal:  Antimicrob Agents Chemother       Date:  1972-05       Impact factor: 5.191

View more
  10 in total

1.  Cloning and expression of a tetracycline resistance determinant from Campylobacter jejuni in Escherichia coli.

Authors:  F C Tenover; D J LeBlanc; P Elvrum
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

2.  Detection of resistant isolates of Campylobacter jejuni by the disc susceptibility method.

Authors:  M Rogol; J Michel
Journal:  Eur J Clin Microbiol       Date:  1984-02       Impact factor: 3.267

3.  Susceptibility of clinical isolates of Campylobacter jejuni to sixteen antimicrobial agents.

Authors:  J Michel; M Rogol; D Dickman
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

4.  Characterization of the porins of Campylobacter jejuni and Campylobacter coli and implications for antibiotic susceptibility.

Authors:  W J Page; G Huyer; M Huyer; E A Worobec
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

5.  In vitro susceptibilities of Campylobacter-like organisms to twenty antimicrobial agents.

Authors:  B M Flores; C L Fennell; K K Holmes; W E Stamm
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

6.  In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound.

Authors:  S A Chartrand; R K Scribner; A H Weber; D F Welch; M I Marks
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

7.  Susceptibility of Campylobacter jejuni and Campylobacter coli to macrolides and related compounds.

Authors:  Z Elharrif; F Mégraud; A M Marchand
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

8.  Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens.

Authors:  J R Carlson; S A Thornton; H L DuPont; A H West; J J Mathewson
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

9.  In vitro susceptibilities of aerotolerant Campylobacter isolates to 22 antimicrobial agents.

Authors:  J A Kiehlbauch; C N Baker; I K Wachsmuth
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

10.  In vitro antimicrobial susceptibility, plasmid analysis, and serotyping of epidemic-associated Campylobacter jejuni.

Authors:  C A Bopp; K A Birkness; I K Wachsmuth; T J Barrett
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.